Bharat Rakshak

Genentech's Generic Battle Ashlea Ebeling, 05.05.04, 12:14 PM ET As the U.S. Food and Drug Administration nears release of a plan for approving generic biological drugs, drug giant Genentech is taking preemptive action to protect its interests. The FDA guidance, expected this summer, will describe h...

Wockhardt buys German firm`s business Source: IRIS (07 May 2004) Wockhardt, (Q, N,C,F)* the pharmaceutical major, announced the acquisition of the German pharmaceutical company, esparma. The deal, made at a consideration of $11 million (Rs. 49 crores), has been uniquely structured with Wockhardt hav...

CVS: Legalize prescription drug imports Wednesday, May 5, 2004 · Last updated 3:01 p.m. PT By MARK SHERMAN ASSOCIATED PRESS WRITER WASHINGTON -- Breaking with others in his industry, the chief executive of CVS Pharmacy called Wednesday for legalizing imports of prescription drugs. The statement by t...

Apollo Hospitals threatening jobs in US: WSJ Wednesday April 28 2004 00:00 IST PTI WASHINGTON : Apollo Hospital 's emergence as a global health care provider in many ways tracks India 's economic trajectory over the past three decades, the Wall Street Journal (WSJ) has said. The company had capitali...

Ranbaxy wins US court battle against Glaxo April 08, 2004 18:09 IST Pharma major Ranbaxy Laboratories on Thursday said it has scored a legal victory with a United States court ruling that its Cefuroxime Exetil product does not infringe upon the patent rights of GlaxoSmithKline. After a full trial, ...

Manju - Here is link for Lupin posting

Lupin launches branded finished dosage in US

Source: IRIS (07 April 2004) http://www.myiris.com/

Zydus Cadila gears up, files 12 ANDAs Source: IRIS (02 April 2004) Gearing up for its foray into the US formulations generic market, Zydus Cadila ended the financial year 2003-4 with 12 ANDA filings. The group, which had started the process in November with 2 ANDA filings, has rounded off the year w...

Lupin launches branded finished dosage in US Source: IRIS (07 April 2004) Lupin Limited (Q, N,C,F)* today announced that it has now launched its anti-infective product SupraxÒ (cefixime Oral Suspension) in the US. The newly established 50 strong pediatric specialty sales force of the company`s subsi...